| Ytd | -81.79% | |
| 1y | -86.10% |
| Open | 2.65 | Prev Close | 2.63 | Low | 2.58 | High | 2.75 | Mkt Cap | 27.22M |
| Vol | 79.41K | Avg Vol | 73.43K | EPS | -2.50 | P/E | N/A | Forward P/E | -1.75 |
| Beta | 0.31 | Short Ratio | 5.18 | Inst. Own | 37.15% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-04 | 50-d Avg | 4.42 | 200-d Avg | 8.15 | 1yr Est | 3.87 |
MCRB News
Seres Therapeutics, Inc. (NASDAQ: MCRB - Get Free Report)'s share price crossed below its 50-day mov
SERES THERAPEUTICS, INC.$300,000,000Common StockPreferred StockDebt SecuritiesWarrantsUnitsWe may of
Seres Therapeutics (NASDAQ:MCRB) reported quarterly earnings of $0.47 per share which beat the analy
Seres Therapeutics reported early SER-155 data, with 80% of patients achieving steroid-free clinical
The study (NCT06801067), conducted at MSK, by Principal Investigator David Faleck, M.D., Director of
The IST was conducted at Memorial Sloan Kettering Cancer Center, with which Seres has a long histor
Wall Street analysts changed outlook on top names, including MCRB, SAFX. See analyst ratings page fo
HC Wainwright & Co. analyst Matthew Keller initiates coverage on Seres Therapeutics (NASDAQ:M
Seres Therapeutics, Inc. (NASDAQ:MCRB), ("Seres" or the "Company"), a leading live b
Seres Therapeutics (NASDAQ:MCRB) reported quarterly losses of $(2.08) per share which missed the ana
Seres Therapeutics, Inc. (NASDAQ:MCRB) (Seres or the Company), a leading live biotherapeutics compan
Data highlight both SER-603's rational design that targets microbial functions linked to mucosal
Presentations DetailsPoster Presentation (Abstract 1726)Title: Effect of investigational, live bioth
Seres Therapeutics (NASDAQ:MCRB) reported quarterly losses of $(1.76) per share which beat the analy
Seres Therapeutics, Inc. (NASDAQ:MCRB), (Seres or the Company), a leading live biotherapeutics compa
Companies Reporting Before The Bell • NIO (NYSE:NIO) is estimated to report quarterly loss at $0.51
Gainers Benson Hill, Inc. (NYSE: BHIL) shares jumped 48.1% to $0.3740.
Companies Reporting Before The Bell • AudioCodes (NASDAQ:AUDC) is estimated to report quarterly ear
Tuesday saw 132 companies set new 52-week lows.
On Thursday, 369 companies hit new 52-week lows.
On Wednesday, 311 stocks hit new 52-week lows.
On Tuesday, 647 companies set new 52-week lows.
On Monday, 369 companies set new 52-week lows.
During the session on Thursday, 461 stocks hit new 52-week lows.
During Tuesday's session, 275 companies made new 52-week lows.
Friday's session saw 169 companies set new 52-week lows.
On Thursday, 283 companies set new 52-week lows.
During Monday's session, 201 stocks hit new 52-week lows.
On Thursday, 128 companies set new 52-week lows.
On Wednesday, 155 companies set new 52-week lows.
During Tuesday's trading, 188 companies set new 52-week lows.